PACS Group, Inc. has achieved impressive revenue and profitability growth over the past year by strategically acquiring underperforming skilled nursing facilities and converting them into higher-acuity transitional care centers. The company’s locally led, centrally supported operating model is a core differentiator that supports clinical quality and operational improvements. However, PACS faces significant regulatory scrutiny with several ongoing DOJ investigations related to Medicare billing practices, which inject uncertainty. Additionally, the company remains in forbearance on its credit facility, constraining liquidity despite strong cash flow from operations. Watching developments in regulatory outcomes and refinancing efforts will be key to understanding PACS’s medium-term trajectory.